Altimmune Stock Probability of Future Stock Price Finishing Under 8.45
| ALT Stock | USD 8.25 0.07 0.86% |
Altimmune |
Altimmune Target Price Odds to finish below 8.45
The tendency of Altimmune Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay under $ 8.45 after 90 days |
| 8.25 | 90 days | 8.45 | about 79.37 |
Based on a normal probability distribution, the odds of Altimmune to stay under $ 8.45 after 90 days from now is about 79.37 (This Altimmune probability density function shows the probability of Altimmune Stock to fall within a particular range of prices over 90 days) . Probability of Altimmune price to stay between its current price of $ 8.25 and $ 8.45 at the end of the 90-day period is about 5.71 .
Considering the 90-day investment horizon Altimmune has a beta of 0.98. This suggests Altimmune market returns are related to returns on the market. As the market goes up or down, Altimmune is expected to follow. Additionally Altimmune has an alpha of 0.2496, implying that it can generate a 0.25 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Altimmune Price Density |
| Price |
Predictive Modules for Altimmune
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Altimmune. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Altimmune Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Altimmune is not an exception. The market had few large corrections towards the Altimmune's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Altimmune, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Altimmune within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.25 | |
β | Beta against Dow Jones | 0.98 | |
σ | Overall volatility | 1.07 | |
Ir | Information ratio | 0.04 |
Altimmune Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Altimmune for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Altimmune can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Altimmune had very high historical volatility over the last 90 days | |
| The company reported the last year's revenue of 426 K. Reported Net Loss for the year was (88.45 M) with loss before taxes, overhead, and interest of (70.52 M). | |
| Altimmune has about 184.76 M in cash with (75.81 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.81. | |
| Altimmune has a poor financial position based on the latest SEC disclosures | |
| Roughly 57.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from gurufocus.com: Altimmune Gains on Nasdaq Biotechnology Index Inclusion |
Altimmune Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Altimmune Stock often depends not only on the future outlook of the current and potential Altimmune's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Altimmune's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 53.2 M | |
| Cash And Short Term Investments | 197.8 M |
Altimmune Technical Analysis
Altimmune's future price can be derived by breaking down and analyzing its technical indicators over time. Altimmune Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Altimmune. In general, you should focus on analyzing Altimmune Stock price patterns and their correlations with different microeconomic environments and drivers.
Altimmune Predictive Forecast Models
Altimmune's time-series forecasting models is one of many Altimmune's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Altimmune's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Altimmune
Checking the ongoing alerts about Altimmune for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Altimmune help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Altimmune had very high historical volatility over the last 90 days | |
| The company reported the last year's revenue of 426 K. Reported Net Loss for the year was (88.45 M) with loss before taxes, overhead, and interest of (70.52 M). | |
| Altimmune has about 184.76 M in cash with (75.81 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.81. | |
| Altimmune has a poor financial position based on the latest SEC disclosures | |
| Roughly 57.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from gurufocus.com: Altimmune Gains on Nasdaq Biotechnology Index Inclusion |
Additional Tools for Altimmune Stock Analysis
When running Altimmune's price analysis, check to measure Altimmune's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Altimmune is operating at the current time. Most of Altimmune's value examination focuses on studying past and present price action to predict the probability of Altimmune's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Altimmune's price. Additionally, you may evaluate how the addition of Altimmune to your portfolios can decrease your overall portfolio volatility.